Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes

Cancer Immunology Immunotherapy

Volumn 45, Issue 1, 1997, Pages 29-36

  Siziopikou, Kalliopi P ^a   Ahn, Mi Chung ^a   Casey, Larry ^a   Silver, Mike ^a   Harris, Jules E ^a   Braun, Donald P ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolar macrophages; Lung cancer; PBL; Tumoricidal activity

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LYMPHOCYTE CULTURE; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ANTIGENS, CD3; ANTIGENS, CD56; ANTIGENS, CD57; CARCINOMA, NON-SMALL-CELL LUNG; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-1; LUNG NEOPLASMS; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030847961     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050397     Document Type: Article

References (50)

1. Anderson TM, Ibayashi Y, Holmes EC, Golub SH (1987) Modification of natural killer activity of lymphocytes infiltrating human lung cancers. Cancer Immunol Immunother 25:65
2. + accessory cells in natural killing of cytomegalovirus infected fibroblasts. J Exp Med 104:180
3. 3 T cell receptors. J Immunol 142:374
4. Braun DP, Harris JE (1981) Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients. J Natl Cancer Inst 67:809
5. Braun DP, Cobleigh MA, Harris JE (1980) Multiple concurrent immunoregulatory defects in cancer patients with depressed PHA-induced lymphocyte DNA synthesis. Clin Immunol Immunopathol 17:89
6. 2 pathways. J Immunol 144:4092
7. DeFrutas E, Chernut R, Grey H, Chiller J (1983) Macrophage dependent activation of antigen specific T cells requires antigen and a soluble monokine. J Immunol 131:23
8. Dührsen V, Uppenhamp M, Uppenkamp I (1986) Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia. Blood 68:577
9. Duggan DB (1994) Cytokines: intercellular messengers of proliferation and function. In: Immunology and inflammation. Basic mechanisms and clinical consequences. McGraw Hill, New York, pp 185-207
10. Engleman EG, Benike CJ, Hoppe RT, Kaplan HS, Berberich FR (1980) Autologous mixed lymphocyte reactions in patients with Hodgkin's disease. J Clin Invest 66:149
11. Erb P, Feldmann M (1979) The role of macrophages in the generation of T helper cells. I. The requirement for macrophages in helper cell induction and characteristics of the macrophage-T cell interaction. Cell Immunol 19:356
12. 3+ T cell receptor-γ+ peripheral blood lymphocyte subpopulation. J Immunol 140:2128
13. Gangemi JD, Olsen GN, Fechtez C, Hightower JA, Bauguess CT, Krech L (1985) Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma. Cancer Immunol Immunother 20:158
14. Gomez J, Pohajdak B, O'Neill S, Wilkins J, Greenberg AH (1985) Activation of rat and human alveolar macrophage intracellular microbicidal activity by a preformed LGL cytokine. J Immunol 135:1194
15. Gottleib A, Fu S, Yu D, Wang C, Halper J, Kunkel H (1979) The nature of the stimulatory cells in human allogeneic and autologous MLC reactions; role of isolated IgM bearing B cells. J Immunol 123:1497
16. Hoover DL, Meltzer MS (1989) Lymphokines as monocyte activators. In: Zembala M, Ascherson GL (eds) Human monocytes. Academic Press, London, p151
17. 2 to its cell surface ligand. Nature 326:298
18. 3+ T cells in fetal human tissue. J Exp Med 168:1941
19. Kan-Mitchell J, Hengst JCD, Kempf RA, Rothbart RK, Simons SM, Brooker AS, Kortes VL, Mitchell MS (1985) Cytotoxic activity of human pulmonary alveolar macrophages. Cancer Res 45:453
20. Kasahara T, Djeu JD, Dougherty SF, Oppenheim JJ (1983) Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol 131:2379
21. Katz P, Mitchell SR, Cupps TR, Evans M, Whalen G (1989) Natural killer cells enhance the early events in B cell activation. In: Ades EW, Lopez C (eds) Natural killer cells and host defense. 5th International Natural Killer Cell Workshop. Karger, Basel, p 59
22. Krammer G, Unanue E (1982) Accessory cell requirements in the proliferative response to T lymphocytes to hemocyanin. Clin Immunol Immunopathol 129:1360
23. Krensky AM, Lanier LL, Engleman EG (1985) Lymphocyte subsets and surface molecules in man. Clin Immunol Res 4:95
24. Kuda T, Yasumoto K, Yano T, Nukahashi H, Sugimashi K, Nomoto K (1987) Role of antitumor activity of alveolar macrophages in lung cancer patients. Cancer Res 47:2199
25. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH (1986) The relationship of CD16 (Leu11) and Leu19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480
26. Lemarble P, Hoidal J, Vesella R, Rinehart J (1980) Human pulmonary macrophage tumor cell cytotoxicity. Blood 55:612
27. Mann D, Abelson L (1980) Monocyte function in mixed lymphocyte reactions. Cell Immunol 56:357
28. Matera L, Avanzi G, Cesano A, Bellone G, Malavasi F, Pegoraro L (1989) Characterization of hemopoietic regulatory factors released by unstimulated LGL. In: Ades EW, Lopez C (eds) Natural killer cells and host defense. 5th International Natural Killer Cell Workshop. Karger, Basel, p 92
29. Michael A, Hackett J, Kumar V, Yuan D (1989) Interaction of B lymphocytes and NK cells. 1989. In: Ades EW, Lopez C (eds) Natural killer cells and host defense. 5th International Natural Killer Cell Workshop. Karger, Basel, p 75
30. Moy MP, Holmes EC, Golub SH (1985) Depression of NK cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res 45:57
31. Naito K, Komatsubara S, Kawai J, Morl K, Muramatusu S (1984) Role of macrophages as modulators but not as stimulators in primary mixed leukocyte reactions. Cell Immunol 88:361
32. Nathan CF, Karnovsky NL, David JR (1971) Alterations of macrophage functions by mediators from lymphocytes. J Exp Med 133:1356
33. Ohlén C, Kling G, Höglung P, Hansson M, Scangos G, Bieberich C, Jay G, Kärre K (1989) Prevention of allogeneic bone marrow graft rejection by H-2 transgene donor mice. Science 246:666
34. Paya CV, Kenmotsu N, Leibson PJ (1989) Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. In: Ades EW, Lopez C (eds) Natural killer cells and host defense. 5th International Natural Killer Cell Workshop. Karger, Basel, p 120
35. Pitchenic AE, Guffee J, Stein-Steilein J (1987) Lung NK and IL 2 activity in lung cancer: a pulmonary compartement of augmented NK activity occurs in patients with bronchogenic carcinoma. Am Rev Respir Dis 136:1327
36. Rhodes J, Plowman P, Bishop M, Lipscomb D (1981) Human macrophage function in cancer: systemic and local changes detected by an assay for FcR expression. J Natl Cancer Inst 66:423
37. Roussel E, Greenberg AH (1989) A heat stable peptide contained in large granular lymphocyte granules that activate macrophages. In: Ades EW, Lopez C (eds) Natural killer cells and host defense. 5th International Natural Killer Cell Workshop. Karger, Basel, p 146
38. Scala G, Allaneva P, Djeu JD, Kasahara T, Ortaldo JR, Herberman RB. Oppenheim JJ (1984) Human large granular lymphocytes are potent producers of interleukin 1. Nature 309:56
39. 11 E rosette receptor. J Clin Invest 79:305
40. 2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules. J Immunol 140:991
41. Siziopikou KP, Harris JE, Casey L, Braun DP (1991) Impaired tumoricidal function of alveolar macrophages from patients with nonsmall cell lung cancer. Cancer 68:1035
42. Sone S (1986) Role of alveolar macrophages in pulmonary neoplasias. Biochem Biophys Acta 823:227
43. Stötter H, Wiebke EA, Tomita S, Belldegrun A, Topalian S, Rosenberg SA, Lotze MT (1989) Cytokines alter target cell susceptibility to lysis. 2. Evaluation of tumor infiltrating lymphocytes. J Immunol 142:1767
44. Sunshine G, Katz D, Czitron A (1982) Heterogeneity of stimulator cells in the murine mixed leukocyte response. Eur J Immunol 12:9
45. Swinburne S, Moore M, Cole P (1982). Human bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells. Br J Cancer 46:625
46. Thomassen MJ, Wiedemann HP, Barna BP, Farmer M, Ahmad M (1988) Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer. Cancer Res 48:3949
47. 11 target structure are active in CD: mediated T cell stimulation. Eur J Immunol 17:1847
48. Wanebo HJ (1979) Immunologic testing as a guide to cancer management. Surg Clin North Am 59:323
49. Weissler JC, Lipscomb MF, Lem VM, Toews GB (1986) Tumor killing by human alveolar macrophages and blood monocytes: decreased cytotoxicity of human alveolar macrophages. Am Rev Repir Dis 134:532
50. Weissler JC, Nicod LP, Toews GB (1987) Pulmonary NK cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis 135:1353